These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 3895019)
1. Immunocytochemical localization of enkephalin-like immunoreactivity in neurons of human hippocampal formation: effects of ageing and Alzheimer's disease. Kulmala HK Neuropathol Appl Neurobiol; 1985; 11(2):105-15. PubMed ID: 3895019 [TBL] [Abstract][Full Text] [Related]
2. Localization of enkephalin-like immunoreactivity to identified axonal and neuronal populations of the rat hippocampus. Gall C; Brecha N; Karten HJ; Chang KJ J Comp Neurol; 1981 May; 198(2):335-50. PubMed ID: 6263955 [TBL] [Abstract][Full Text] [Related]
3. Comparative mapping of opioid receptors and enkephalin immunoreactive nerve terminals in the rat hippocampus. A radiohistochemical and immunocytochemical study. Stengaard-Pedersen K Histochemistry; 1983; 79(3):311-33. PubMed ID: 6317617 [TBL] [Abstract][Full Text] [Related]
4. Some enkephalin- or VIP-immunoreactive hippocampal pyramidal cells contain neurofibrillary tangles in the brains of aged humans and persons with Alzheimer's disease. Kulmala HK Neurochem Pathol; 1985; 3(1):41-51. PubMed ID: 2410823 [TBL] [Abstract][Full Text] [Related]
5. Cholecystokinin-, enkephalin-, and substance P-like immunoreactivity in the dentate area, hippocampus, and subiculum of the domestic pig. Holm IE; Geneser FA; Zimmer J J Comp Neurol; 1993 May; 331(3):310-25. PubMed ID: 7685777 [TBL] [Abstract][Full Text] [Related]
6. Aberrant localization of MAP5 immunoreactivity in the hippocampal formation in Alzheimer's disease. Geddes JW; Lundgren K; Kim YK J Neurosci Res; 1991 Sep; 30(1):183-91. PubMed ID: 1795403 [TBL] [Abstract][Full Text] [Related]
7. c-fos protein-like immunoreactivity: distribution in the human brain and over-expression in the hippocampus of patients with Alzheimer's disease. Zhang P; Hirsch EC; Damier P; Duyckaerts C; Javoy-Agid F Neuroscience; 1992; 46(1):9-21. PubMed ID: 1594107 [TBL] [Abstract][Full Text] [Related]
8. Alterations in neurofilament protein immunoreactivity in human hippocampal neurons related to normal aging and Alzheimer's disease. Vickers JC; Riederer BM; Marugg RA; Buée-Scherrer V; Buée L; Delacourte A; Morrison JH Neuroscience; 1994 Sep; 62(1):1-13. PubMed ID: 7816192 [TBL] [Abstract][Full Text] [Related]
9. Synaptic loss reflected by secretoneurin-like immunoreactivity in the human hippocampus in Alzheimer's disease. Kaufmann WA; Barnas U; Humpel C; Nowakowski K; DeCol C; Gurka P; Ransmayr G; Hinterhuber H; Winkler H; Marksteiner J Eur J Neurosci; 1998 Mar; 10(3):1084-94. PubMed ID: 9753176 [TBL] [Abstract][Full Text] [Related]
10. Distribution of glutamate receptor subunit NMDAR1 in the hippocampus of normal elderly and patients with Alzheimer's disease. Ikonomovic MD; Mizukami K; Warde D; Sheffield R; Hamilton R; Wenthold RJ; Armstrong DM Exp Neurol; 1999 Nov; 160(1):194-204. PubMed ID: 10630204 [TBL] [Abstract][Full Text] [Related]
11. Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains. Westlake TM; Howlett AC; Bonner TI; Matsuda LA; Herkenham M Neuroscience; 1994 Dec; 63(3):637-52. PubMed ID: 7898667 [TBL] [Abstract][Full Text] [Related]
12. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain. Snow AD; Sekiguchi RT; Nochlin D; Kalaria RN; Kimata K Am J Pathol; 1994 Feb; 144(2):337-47. PubMed ID: 8311117 [TBL] [Abstract][Full Text] [Related]
13. Role of the senile plaque in neuropeptide deficits of Alzheimer's disease. Kulmala HK; Hutton JT Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):625-8. PubMed ID: 2868494 [TBL] [Abstract][Full Text] [Related]
14. N-methyl-D-aspartate receptor complex in the hippocampus of elderly, normal individuals and those with Alzheimer's disease. Ułas J; Brunner LC; Geddes JW; Choe W; Cotman CW Neuroscience; 1992 Jul; 49(1):45-61. PubMed ID: 1407551 [TBL] [Abstract][Full Text] [Related]
15. The second layer neurones of the entorhinal cortex and the perforant path in physiological ageing and Alzheimer's disease. Moryś J; Sadowski M; Barcikowska M; Maciejewska B; Narkiewicz O Acta Neurobiol Exp (Wars); 1994; 54(1):47-53. PubMed ID: 8023713 [TBL] [Abstract][Full Text] [Related]
16. Changes in hippocampal GABABR1 subunit expression in Alzheimer's patients: association with Braak staging. Iwakiri M; Mizukami K; Ikonomovic MD; Ishikawa M; Hidaka S; Abrahamson EE; DeKosky ST; Asada T Acta Neuropathol; 2005 May; 109(5):467-74. PubMed ID: 15759131 [TBL] [Abstract][Full Text] [Related]
17. Distribution of chromogranin B-like immunoreactivity in the human hippocampus and its changes in Alzheimer's disease. Marksteiner J; Lechner T; Kaufmann WA; Gurka P; Humpel C; Nowakowski C; Maier H; Jellinger KA Acta Neuropathol; 2000 Aug; 100(2):205-12. PubMed ID: 10963369 [TBL] [Abstract][Full Text] [Related]
18. Non-plaque dystrophic dendrites in Alzheimer hippocampus: a new pathological structure revealed by glutamate receptor immunocytochemistry. Aronica E; Dickson DW; Kress Y; Morrison JH; Zukin RS Neuroscience; 1998 Feb; 82(4):979-91. PubMed ID: 9466422 [TBL] [Abstract][Full Text] [Related]